Xenical Research Today is a free monthly online journal that collates and summarizes the latest research about Xenical, including details on orlistat, side-effects, obesity, weight loss, dieting. | ||||||||
|
Beta-lactam congeners of orlistat as inhibitors of fatty acid synthase.Zhang W, Richardson RD, Chamni S, Smith JW, Romo D Department of Chemistry, Texas A&M University, College Station, TX 77842-3012, USA. Beta-lactam derivatives of orlistat were prepared and their inhibitory activities toward the thioesterase domain of fatty acid synthase (FAS-TE) were evaluated using a recombinant form of the enzyme. While in general these derivatives showed lower potency compared to beta-lactones, a reasonably potent, lead compound (-)-9 (IC(50)=8.6microM) was discovered that suggests that this class of compounds should be evaluated further. Published 3 April 2008 in Bioorg Med Chem Lett, 18(7): 2491-4.
© 2004-2008 Xenical Research Today. All Rights Reserved. |
| ||||||